ClinicalTrials.gg
CompletedNCT02792777VOICeUpdated Nov 15, 2019Results posted

Concept Mapping as a Scalable Method for Identifying Patient-Important Outcomes

An observational study in Concept Mapping Versus Interviews, sponsored by Thomas Jefferson University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-15.

Sponsored by Thomas Jefferson University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
148
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to improve the methods with which researchers identify patient centered outcomes for use in research. Specifically, the investigators will test the application of concept mapping as compared to one-on-one interviews as a comprehensive and efficient method of identifying patient-important outcomes for use in research.

Read the detailed description

This is an observational study comparing two methods - concept mapping and one-on-one interviews. The investigators will test the methods themselves by comparing the comprehensiveness of the lists of patient-important outcomes obtained through each method (primary outcome) as well as the efficiency, as measured by resource intensiveness, of the methods (secondary outcome). The aims of this study will be tested with adult patients with moderately to poorly controlled diabetes mellitus who receive care at a large, urban, academic health system. In order to allow comparisons of the comprehensiveness of the methods in producing patient-important outcomes regardless of the healthcare setting in which outcomes are elicited, the investigators will recruit patients for the interview group from 3 different care settings: an acute care visit (in the emergency department), a post-acute care visit (within 1 week of a hospital discharge), and a routine primary care visit. Target sample size within each healthcare setting is 30 patients, which is the anticipated number needed for thematic saturation. The investigators will then recruit patient-participants from existing clinical and research databases for 3 separate concept mapping groups, each with a target of 20 patients. In Aim 2, the investigators will test the hypothesis that concept mapping in a research setting produces outcomes consistent with those elicited from patients in the "real-world" settings. In Aim 3, the investigators will assess the overall resource utilization, assessed primarily by time required from patients, the research team, and the advisory board, of qualitative interviews conducted to thematic saturation within a single healthcare setting compared to resources used for a single iteration of concept mapping.

Findings from this work will improve patient-centered outcomes research methods by providing researchers with information about standardized scalable methods to identify patient-important outcomes for use in research studies, so that individual patients are able to select outcomes that are most useful to them. In addition to providing insight regarding methods for eliciting patient-centered outcomes, the study will also provide valuable information to stakeholders regarding how patients' priorities vary across the care continuum. The investigators will report how findings from concept mapping apply across healthcare settings, and the degree to which patient priorities (based on interviews) differ across healthcare settings. If concept mapping results (collected in the research setting) capture the priorities identified by patients across different healthcare settings, this finding would enhance researchers' ability to perform studies in different, or multiple, settings. If the findings do not generalize across settings, this will be a valuable finding demonstrating that patient priorities differ across interview settings and patient acuity and will validate researchers' needs to be specific about the setting in which they choose to perform research to ensure they are reaching their intended patient population.

The work is being performed in close collaboration with the Patient and Key Stakeholder Advisory Board (PAKSAB) - equal partners with the research team who have been involved with the proposal from inception. PAKSAB members will be part of the research team throughout conducting the aims and assisting with all analysis and data interpretation.

02

Conditions studied

  • Concept Mapping Versus Interviews

Keywords

  • Concept Mapping
  • VOICe
  • Interviews
  • Patient-Centered Research
03

In context

Lead sponsor

Thomas Jefferson University is the lead sponsor of 390 studies on the registry; 72 are open to participants now.

Of its 45 completed or terminated interventional studies of FDA-regulated products, 21 (47%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The investigators aim to engage a discrete population of patients who have recently sought care at Thomas Jefferson University for treatment needs related to moderately to poorly controlled diabetes. Consistent with the overall population served by Jefferson, the investigators expect greater than 50% of enrolled patients to be African American and approximately 30% of them to be at the \<20% federal poverty line. All data will be collected prospectively. The investigators decided to engage patients with moderately to poorly controlled DM because these patients have a known high risk of severe complications related to poor diabetes control, and a significant proportion of patients remain poorly controlled despite available therapies. The investigators thus determined in discussion with the PAKSAB that this population is a good candidate for testing the method of concept mapping to identify patient-important outcomes.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient (age 18 and older)

    • English speaking
    • Provide informed consent
  • Diagnosis of moderately to poorly controlled diabetes mellitus (DM) defined as follows (for interview groups):

    • Acute care setting: patient in the Jefferson Emergency Department (ED) for a diabetes-related problem determined to require medical treatment
    • Post-acute care setting: patient was discharged from the Jefferson Family Medicine Associates (JFMA) hospital service within the past 7 days after admission for a diabetes-related problem
    • Primary care setting: patient currently attending a routine scheduled care visit (not urgent need) at the JFMA practice and has at least 2 measurements of HgbA1C > 7.5 in the prior one year
  • Diagnosis of moderately to poorly controlled diabetes mellitus (DM) defined as follows (for concept mapping groups):

    • Acute care setting: patient within the Jefferson ED patient contact database (see below) who has had a visit to the Jefferson ED over the past 6 months (as determined on chart review) for a diabetes-related problem
    • Post-acute care setting: patient was discharged from the JFMA hospital service within the past 6 months after admission for a diabetes-related problem
    • Primary care setting: patient has had routine scheduled office visit within the past 6 months to the JFMA practice and has at least 2 measurements of HgbA1C > 7.5 in the prior one year

Exclusion criteria

Exclusion Criteria:

  • Patient has had a significant permanent complication related to DM including:

    • End stage renal disease
    • History of amputation
    • Blindness related to diabetes complication
  • Patient undergoing medical clearance for a detox center or any involuntary court or magistrate order
  • Patient in police custody or currently incarcerated individual
  • Patient who has, in their clinician's best judgment, major communication barriers such as visual or hearing impairment or dementia that would compromise their ability to give written informed consent
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
148 participants (actual)
Patient registry
No

Groups and cohorts

  • Interviews

    Interview participants will be recruited from 3 different care settings: an acute care visit (in the emergency department), a post-acute care visit (within 1 week of a hospital discharge), and a routine primary care visit. Target sample size within each healthcare setting is 30 patients, which is the anticipated number needed for thematic saturation. The total recruitment goal for this cohort is 90-120 participants.

    Other: Interviews

  • Concept Mapping

    Concept mapping participants will be recruited from existing clinical and research databases for 3 separate concept mapping groups, each with a target of 20 patients. The total recruitment goal for this cohort is 60 people.

    Other: Concept Mapping (CM)

Interventions

  • OtherInterviews

    Patients will be engaged in open-ended, semi-structured qualitative interviews, which will be performed one-on-one either in person or over the phone (depending on the healthcare setting that they are recruited from). Qualitative interviews will be audio recorded, with the patient's permission, transcribed, de-identified and entered into NVivo software for coding and analysis.

  • OtherConcept Mapping (CM)

    The CM process consists of 3 steps that take place over 3 sessions: Step 1: Generation of Ideas- Participants brainstorm and generate responses to the focus statement. Once the group agrees that no new statements are being generated, the list of statements is reviewed within the group. Step 2: Structuring of Statements- Each participant is given a set of sort cards and asked to sort the statements into piles. Participants then rate each idea regarding importance. Research staff enters this information into the CM software. Concept Systems Global Software generates point maps using a technique that detects underlying similarities/differences between statements. The CM software then uses hierarchical cluster analysis to draw boundaries around the point map to create conceptual clusters. Step 3: Interpretation- The CM group revises the concept map. Participants review the cluster names suggested by the software and decide upon final naming of each cluster as a group.

06

What researchers measure

Primary outcomes

  1. Comprehensiveness of Interviews as Compared to One Concept Mapping Group

    The investigators will use a qualitative content analysis approach to analyze interview transcripts from one healthcare setting, with one of the codes being "goals". All ideas coded to "goals" that are in any way relevant to patients' diabetes care will be extracted to create a list of patient-important outcomes. The investigators will then determine the proportion of patient-important outcomes identified in the interviews from one healthcare setting that are present in the list of patient-important outcomes generated from the initial concept mapping group during the brainstorming session. The investigators will also identify the presence of unique outcomes found in each method.

    Time frame: Interviewed patients participated for 1 day; Concept mapping patients participated for 3 days

  2. Comprehensiveness of Interviews Compared to Three Concept Mapping Groups

    The investigators will use a qualitative content analysis approach to analyze interview transcripts, with one of the codes being "goals". All ideas coded to "goals" that are in any way relevant to patients' diabetes care will be extracted to create a list of patient-important outcomes. The investigators will then determine the proportion of patient-important outcomes identified in interviews that are present in an aggregate list of patient-important outcomes generated from the brainstorming session of all three concept mapping groups. The investigators will also identify the presence of additional patient-important outcomes in three concept mapping groups that were not identified in interviews.

    Time frame: Interviewed patients participated for 1 day; One group of concept mapping patients participated for 3 days

  3. Comprehensiveness of Concept Mapping

    The investigators will measure the comprehensiveness of outcomes elicited in one concept mapping group compared to multiple groups. The investigators will assess "concept mapping saturation," wherein we compare the patient-important outcomes that emerge from each CM group. The investigators will use the outcomes from our first group as the "baseline data," and will determine the amount of new data added from including a second/third group. This assessment will allow us to draw a basic "concept mapping saturation curve."

    Time frame: 3 days for one concept mapping group

Secondary outcomes

  1. Comparison of Method Efficiency in Terms of Time

    The investigators will assess the efficiency of implementation of the two methods, with efficiency including time required by researchers (team of 3) and patient-participants to complete each method. The investigators will compare the efficiency of conducting one concept mapping iteration (24 participants) to the efficiency of performing one set of interviews done to theme saturation (30 interviews). This efficiency analysis is structured for what would need to be budgeted in a grant application, and will provide useful information for general planning needs for method implementation.

    Time frame: Interviewed patients participated for 1 day; Concept mapping patients participated for 3 days

  2. Comparison of Method Efficiency in Terms of Cost

    The investigators will assess the efficiency of implementation of the two methods, with efficiency assessed by cost to complete a single concept mapping iteration (24 participants) and cost to complete one set of interviews performed to saturation (30 interviews). This efficiency analysis is structured for what would need to be budgeted in a grant application, and will provide useful information for general planning needs for method implementation.

    Time frame: Interviewed patients participated for 1 day; Concept mapping patients participated for 3 days

07

Results

Posted Oct 21, 2019
Limitations and caveats
Limited generalizability due to all enrollments in same health system; Potential selection bias to more engaged/motivated patients; Method efficiency may vary depending on size of research team, patient incentives, and analysis software needed.

Participant flow

Participant flow — Overall Study
MilestoneInterviewsConcept Mapping
Started9652
Completed8952
Not completed70
Withdrew: Withdrawal by subject20
Withdrew: Recording malfunction20
Withdrew: Later determined to be ineligible20
Withdrew: Participant interviewed twice10

Outcome measures

PrimaryComprehensiveness of Interviews as Compared to One Concept Mapping Group

The investigators will use a qualitative content analysis approach to analyze interview transcripts from one healthcare setting, with one of the codes being "goals". All ideas coded to "goals" that are in any way relevant to patients' diabetes care will be extracted to create a list of patient-important outcomes. The investigators will then determine the proportion of patient-important outcomes identified in the interviews from one healthcare setting that are present in the list of patient-important outcomes generated from the initial concept mapping group during the brainstorming session. The investigators will also identify the presence of unique outcomes found in each method.

Time frame:
Interviewed patients participated for 1 day; Concept mapping patients participated for 3 days
Reported as:
Number · Reported patient-important outcomes
Comprehensiveness of Interviews as Compared to One Concept Mapping Group
Reported patient-important outcomesInterviewsConcept Mapping
Total number of outcomes2633
Number of unique outcomes613
PrimaryComprehensiveness of Interviews Compared to Three Concept Mapping Groups

The investigators will use a qualitative content analysis approach to analyze interview transcripts, with one of the codes being "goals". All ideas coded to "goals" that are in any way relevant to patients' diabetes care will be extracted to create a list of patient-important outcomes. The investigators will then determine the proportion of patient-important outcomes identified in interviews that are present in an aggregate list of patient-important outcomes generated from the brainstorming session of all three concept mapping groups. The investigators will also identify the presence of additional patient-important outcomes in three concept mapping groups that were not identified in interviews.

Time frame:
Interviewed patients participated for 1 day; One group of concept mapping patients participated for 3 days
Reported as:
Number · Reported patient-important outcomes
Comprehensiveness of Interviews Compared to Three Concept Mapping Groups
Reported patient-important outcomesInterviewsConcept Mapping
Total Number of Outcomes2638
Unique Number of Outcomes315
PrimaryComprehensiveness of Concept Mapping

The investigators will measure the comprehensiveness of outcomes elicited in one concept mapping group compared to multiple groups. The investigators will assess "concept mapping saturation," wherein we compare the patient-important outcomes that emerge from each CM group. The investigators will use the outcomes from our first group as the "baseline data," and will determine the amount of new data added from including a second/third group. This assessment will allow us to draw a basic "concept mapping saturation curve."

Time frame:
3 days for one concept mapping group
Reported as:
Number · Reported patient-important outcomes
Comprehensiveness of Concept Mapping
Reported patient-important outcomesConcept Mapping
One Group33
Two Groups36
Three Groups38
SecondaryComparison of Method Efficiency in Terms of Time

The investigators will assess the efficiency of implementation of the two methods, with efficiency including time required by researchers (team of 3) and patient-participants to complete each method. The investigators will compare the efficiency of conducting one concept mapping iteration (24 participants) to the efficiency of performing one set of interviews done to theme saturation (30 interviews). This efficiency analysis is structured for what would need to be budgeted in a grant application, and will provide useful information for general planning needs for method implementation.

Time frame:
Interviewed patients participated for 1 day; Concept mapping patients participated for 3 days
Reported as:
Number · Hours
Comparison of Method Efficiency in Terms of Time
HoursInterviewsConcept Mapping
Patient travel02
Patient participation16
Research team trainings2011
Research team participant recruitment6659
Research team travel6012
Research team conducting method3818
Research team data analysis1334
SecondaryComparison of Method Efficiency in Terms of Cost

The investigators will assess the efficiency of implementation of the two methods, with efficiency assessed by cost to complete a single concept mapping iteration (24 participants) and cost to complete one set of interviews performed to saturation (30 interviews). This efficiency analysis is structured for what would need to be budgeted in a grant application, and will provide useful information for general planning needs for method implementation.

Time frame:
Interviewed patients participated for 1 day; Concept mapping patients participated for 3 days
Reported as:
Number · Dollars
Comparison of Method Efficiency in Terms of Cost
DollarsInterviewsConcept Mapping
Patient Incentives7503,000
Transcription1,0000
Data Analysis Software1,3802,000

Adverse events

Collected over 1 year, 9 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Interviews———
Concept Mapping———

Baseline characteristics

Age, Continuous
Age, Continuous(years)InterviewsConcept MappingTotal
Mean54.6 ± 13.855.6 ± 14.754.9 ± 14.1
Sex: Female, Male
Sex: Female, Male(Participants)InterviewsConcept MappingTotal
Female492473
Male402666
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)InterviewsConcept MappingTotal
Hispanic or Latino8311
Not Hispanic or Latino8049129
Unknown or Not Reported101
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)InterviewsConcept MappingTotal
Race — Black or African American6042102
Race — Caucasian/White24529
Race — Other448
Race — Unknown or not reported112
Region of Enrollment
Region of Enrollment(participants)InterviewsConcept MappingTotal
United States8952141
08

Study locations

1 site
  • ThomasJeffersonU
    Philadelphia, Pennsylvania 19107, United States
09

References and documents

Publications

  • Gentsch AT, Reed MK, Cunningham A, Chang AM, Kahn S, Kovalsky D, Doty AMB, Mills G, Hollander JE, Rising KL. "Once I take that one bite": the consideration of harm reduction as a strategy to support dietary change for patients with diabetes. BMC Endocr Disord. 2024 Jan 2;24(1):3. doi: 10.1186/s12902-023-01529-6. PubMed 38166864 ↗
  • LaNoue M, Gentsch A, Cunningham A, Mills G, Doty AMB, Hollander JE, Carr BG, Loebell L, Weingarten G, Rising KL. Eliciting patient-important outcomes through group brainstorming: when is saturation reached? J Patient Rep Outcomes. 2019 Feb 4;3(1):9. doi: 10.1186/s41687-019-0097-2. PubMed 30714080 ↗
  • Rising KL, LaNoue M, Gentsch AT, Doty AMB, Cunningham A, Carr BG, Hollander JE, Latimer L, Loebell L, Weingarten G, White N, Mills G. The power of the group: comparison of interviews and group concept mapping for identifying patient-important outcomes of care. BMC Med Res Methodol. 2019 Jan 8;19(1):7. doi: 10.1186/s12874-018-0656-x. PubMed 30621586 ↗

Study documents

  • Protocol and statistical analysis plan · May 6, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02792777
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Sponsor
First posted
Jun 8, 2016
Start date
Jan 2016
Primary completion
Jan 29, 2018
Completion
Mar 2, 2018
Results posted
Oct 21, 2019
Last update
Nov 15, 2019

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion